---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-011712"
form_type: "8-K"
ticker: "STRO"
cik: "0001382101"
company_name: "SUTRO BIOPHARMA, INC."
filed_at: "2022-06-16T23:59:59+00:00"
generated_at: "2026-06-25T01:11:09.203299+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Sutro Biopharma to present updated corporate presentation at JMP conference

## Summary
- Corporate presentation attached as Exhibit 99.1, available on company website.
- Presentation covers company overview as of June 2022; no financial or pipeline data disclosed in filing.
- No material changes to business, guidance, or clinical programs announced in the 8-K.

## SEC filing metadata
- accession: 0000950170-22-011712
- form_type: 8-K
- ticker: STRO
- cik: 0001382101
- company_name: SUTRO BIOPHARMA, INC.
- filed_at: 2022-06-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1382101/000095017022011712/0000950170-22-011712-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1382101/000095017022011712/stro-20220616.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-011712
- JSON: https://secwatch.observer/filing/0000950170-22-011712.json
- Plain text: https://secwatch.observer/filing/0000950170-22-011712.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.